Doximity (NYSE:DOCS – Get Free Report) had its price objective dropped by analysts at JPMorgan Chase & Co. from $33.00 to $28.00 in a report issued on Thursday,Benzinga reports. The brokerage currently has a “neutral” rating on the stock. JPMorgan Chase & Co.‘s price objective would indicate a potential upside of 47.95% from the stock’s current price.
DOCS has been the subject of several other research reports. Loop Capital set a $31.00 price target on Doximity in a research note on Tuesday, March 17th. Truist Financial reissued a “hold” rating and issued a $19.00 price target (down from $29.00) on shares of Doximity in a research note on Thursday. KeyCorp cut Doximity from an “overweight” rating to a “sector weight” rating in a research note on Thursday. Piper Sandler boosted their price target on Doximity from $40.00 to $42.00 and gave the company an “overweight” rating in a research note on Friday, February 20th. Finally, Evercore cut Doximity from an “outperform” rating to an “in-line” rating and set a $25.00 price target for the company. in a research note on Wednesday, April 8th. Two investment analysts have rated the stock with a Strong Buy rating, seven have given a Buy rating and fourteen have issued a Hold rating to the stock. Based on data from MarketBeat, the company currently has a consensus rating of “Hold” and an average price target of $30.62.
View Our Latest Report on Doximity
Doximity Trading Up 5.1%
Doximity announced that its board has authorized a stock buyback program on Thursday, February 5th that authorizes the company to repurchase $500.00 million in shares. This repurchase authorization authorizes the company to purchase up to 8% of its stock through open market purchases. Stock repurchase programs are often an indication that the company’s board believes its shares are undervalued.
Insider Activity at Doximity
In related news, insider Siddharth Sitaram sold 2,309 shares of the business’s stock in a transaction that occurred on Monday, May 11th. The stock was sold at an average price of $25.77, for a total value of $59,502.93. Following the completion of the sale, the insider directly owned 89,396 shares in the company, valued at approximately $2,303,734.92. The trade was a 2.52% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, Director Kira Scherer Wampler sold 9,000 shares of the business’s stock in a transaction that occurred on Thursday, May 7th. The stock was sold at an average price of $26.06, for a total value of $234,540.00. Following the completion of the sale, the director owned 19,839 shares of the company’s stock, valued at approximately $517,004.34. This trade represents a 31.21% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last 90 days, insiders sold 18,055 shares of company stock valued at $456,061. Corporate insiders own 31.30% of the company’s stock.
Institutional Investors Weigh In On Doximity
Institutional investors and hedge funds have recently added to or reduced their stakes in the stock. Root Financial Partners LLC acquired a new stake in Doximity in the 3rd quarter worth approximately $30,000. Whittier Trust Co. of Nevada Inc. lifted its holdings in Doximity by 59.5% in the 3rd quarter. Whittier Trust Co. of Nevada Inc. now owns 480 shares of the company’s stock worth $35,000 after purchasing an additional 179 shares during the last quarter. Northwestern Mutual Wealth Management Co. lifted its holdings in Doximity by 99.5% in the 4th quarter. Northwestern Mutual Wealth Management Co. now owns 796 shares of the company’s stock worth $35,000 after purchasing an additional 397 shares during the last quarter. Toth Financial Advisory Corp lifted its holdings in Doximity by 100.0% in the 4th quarter. Toth Financial Advisory Corp now owns 1,000 shares of the company’s stock worth $44,000 after purchasing an additional 500 shares during the last quarter. Finally, Atlantic Union Bankshares Corp lifted its holdings in Doximity by 136.9% in the 3rd quarter. Atlantic Union Bankshares Corp now owns 616 shares of the company’s stock worth $45,000 after purchasing an additional 356 shares during the last quarter. 87.19% of the stock is currently owned by institutional investors and hedge funds.
Key Stories Impacting Doximity
Here are the key news stories impacting Doximity this week:
- Positive Sentiment: Doximity said revenue still grew year over year, and its earnings call highlighted strong engagement from AI tool adoption, suggesting the platform is gaining traction with physicians. Doximity Stock Falls on Q4 Earnings Miss, Revenues Beat, Margins Down
- Positive Sentiment: Doximity announced a partnership with Aledade to bring clinical AI tools into value-based care workflows, which could support longer-term adoption and monetization. DOCS Teams Up With Aledade to Bring Clinical AI to Value-Based Care
- Neutral Sentiment: Several articles noted the stock has become technically oversold after a sharp selloff, which could set up a bounce if sentiment improves. Down 25.7% in 4 Weeks, Here’s Why Doximity (DOCS) Looks Ripe for a Turnaround
- Negative Sentiment: Doximity missed quarterly earnings estimates and issued fiscal 2027 revenue guidance below Wall Street expectations, raising concerns that growth is slowing. Doximity, Inc. (DOCS) Q4 2026 Earnings Call Transcript
- Negative Sentiment: Analysts turned more cautious, with multiple firms cutting price targets or downgrading the stock, including Baird, Wells Fargo, BTIG, JPMorgan, Mizuho, BMO, Needham and Truist. DOCS vs. HIMS: Which Stock Is the Better Value Option?
- Negative Sentiment: Investor caution also increased after insider selling was disclosed, even though it was tied to a pre-arranged 10b5-1 plan and tax withholding. Doximity (NYSE:DOCS) Insider Siddharth Sitaram Sells 2,309 Shares
About Doximity
Doximity, trading as DOCS, operates a digital professional network and communications platform designed primarily for clinicians. Headquartered in San Francisco, the company connects physicians, nurse practitioners, physician assistants and other healthcare professionals, providing tools that streamline clinical communication, telehealth delivery and access to specialty-specific medical information. Its platform is positioned as a professional hub where clinicians manage their workflows, stay current with medical news and collaborate securely with peers.
The company’s offerings include secure messaging and video telehealth capabilities that enable clinicians to consult with patients and colleagues while protecting patient information.
Featured Articles
- Five stocks we like better than Doximity
- Viking Sails to All-Time Highs—Fundamentals Signal More to Come
- Datavalut Gains Traction: 5 Reasons to Sell Now
- TMC Stock: Why This Pre-Revenue Miner Is Worth Watching
- The Power Grid Is Dying—Is It Time to Buy Its Replacement?
Receive News & Ratings for Doximity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Doximity and related companies with MarketBeat.com's FREE daily email newsletter.
